Thank you very much, Mr. Chair.
Welcome to all the witnesses.
I would also like, Mr. Chair, to have an indication when I have one minute left. Thank you.
The first question I have is to Professor Lexchin on the mandatory provision that the results of a clinical trial be made public within one year.
Who would have access to that information? It's useless for the general public, of course. In your view, who should have access, and under what rules? On the one hand, there is the greatest benefit possible for the potential patients, and on the other hand we don't want to have anybody using it for unfair commercial practices.